Literature DB >> 23633922

Biologic effects of dopamine on tumor vasculature in ovarian carcinoma.

Myrthala Moreno-Smith1, Sun Joo Lee, Chunhua Lu, Archana S Nagaraja, Guangan He, Rajesha Rupaimoole, Hee Dong Han, Nicholas B Jennings, Ju-Won Roh, Masato Nishimura, Yu Kang, Julie K Allen, Guillermo N Armaiz, Koji Matsuo, Mian M K Shahzad, Justin Bottsford-Miller, Robert R Langley, Steve W Cole, Susan K Lutgendorf, Zahid H Siddik, Anil K Sood.   

Abstract

Chronic sympathetic nervous system activation results in increased angiogenesis and tumor growth in orthotopic mouse models of ovarian carcinoma. However, the mechanistic effects of such activation on the tumor vasculature are not well understood. Dopamine (DA), an inhibitory catecholamine, regulates the functions of normal and abnormal blood vessels. Here, we examined whether DA, an inhibitory catecholamine, could block the effects of chronic stress on tumor vasculature and tumor growth. Exogenous administration of DA not only decreased tumor microvessel density but also increased pericyte coverage of tumor vessels following daily restraint stress in mice. Daily restraint stress resulted in significantly increased tumor growth in the SKOV3ip1 and HeyA8 ovarian cancer models. DA treatment blocked stress-mediated increases in tumor growth and increased pericyte coverage of tumor endothelial cells. Whereas the antiangiogenic effect of DA is mediated by dopamine receptor 2 (DR2), our data indicate that DA, through DR1, stimulates vessel stabilization by increasing pericyte recruitment to tumor endothelial cells. DA significantly stimulated migration of mouse 10T1/2 pericyte-like cells in vitro and increased cyclic adenosine mono-phosphate (cAMP) levels in these cells. Moreover, DA or the DR1 agonist SKF 82958 increased platinum concentration in SKOV3ip1 tumor xenografts following cisplatin administration. In conclusion, DA stabilizes tumor blood vessels through activation of pericyte cAMP-protein kinase A signaling pathway by DR1. These findings could have implications for blocking the stimulatory effects of chronic stress on tumor growth.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23633922      PMCID: PMC3638353          DOI: 10.1593/neo.121412

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  36 in total

Review 1.  Signaling through focal adhesion kinase.

Authors:  D D Schlaepfer; C R Hauck; D J Sieg
Journal:  Prog Biophys Mol Biol       Date:  1999       Impact factor: 3.667

Review 2.  Gating by cyclic AMP: expanded role for an old signaling pathway.

Authors:  R Iyengar
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728

3.  Stress hormone-mediated invasion of ovarian cancer cells.

Authors:  Anil K Sood; Robert Bhatty; Aparna A Kamat; Charles N Landen; Liz Han; Premal H Thaker; Yang Li; David M Gershenson; Susan Lutgendorf; Steven W Cole
Journal:  Clin Cancer Res       Date:  2006-01-15       Impact factor: 12.531

4.  Beta-endorphin and catecholamine concentrations during chronic and acute stress in intensive care patients.

Authors:  C Schmidt; K Kraft
Journal:  Eur J Med Res       Date:  1996-09-20       Impact factor: 2.175

Review 5.  Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.

Authors:  Rakesh K Jain
Journal:  Science       Date:  2005-01-07       Impact factor: 47.728

6.  Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.

Authors:  Frank Winkler; Sergey V Kozin; Ricky T Tong; Sung-Suk Chae; Michael F Booth; Igor Garkavtsev; Lei Xu; Daniel J Hicklin; Dai Fukumura; Emmanuelle di Tomaso; Lance L Munn; Rakesh K Jain
Journal:  Cancer Cell       Date:  2004-12       Impact factor: 31.743

7.  Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice.

Authors:  J Yoneda; H Kuniyasu; M A Crispens; J E Price; C D Bucana; I J Fidler
Journal:  J Natl Cancer Inst       Date:  1998-03-18       Impact factor: 13.506

8.  Control of adhesion-dependent cell survival by focal adhesion kinase.

Authors:  S M Frisch; K Vuori; E Ruoslahti; P Y Chan-Hui
Journal:  J Cell Biol       Date:  1996-08       Impact factor: 10.539

9.  Comparative distribution and excretion of carboplatin and cisplatin in mice.

Authors:  Z H Siddik; M Jones; F E Boxall; K R Harrap
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

10.  Regulation of actin microfilament integrity in living nonmuscle cells by the cAMP-dependent protein kinase and the myosin light chain kinase.

Authors:  N J Lamb; A Fernandez; M A Conti; R Adelstein; D B Glass; W J Welch; J R Feramisco
Journal:  J Cell Biol       Date:  1988-06       Impact factor: 10.539

View more
  27 in total

Review 1.  Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma.

Authors:  Thamara E Osinga; Thera P Links; Robin P F Dullaart; Karel Pacak; Anouk N A van der Horst-Schrivers; Michiel N Kerstens; Ido P Kema
Journal:  FASEB J       Date:  2017-03-06       Impact factor: 5.191

2.  Cancer subclonal genetic architecture as a key to personalized medicine.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

Review 3.  Novel roles of perivascular nerves on neovascularization.

Authors:  Lei Hao; Zhongmin Zou; Hong Tian; Yubo Zhang; Chuan Song; Huchuan Zhou; Lei Liu
Journal:  Neurol Sci       Date:  2014-11-29       Impact factor: 3.307

Review 4.  Dopamine receptors - IUPHAR Review 13.

Authors:  Jean-Martin Beaulieu; Stefano Espinoza; Raul R Gainetdinov
Journal:  Br J Pharmacol       Date:  2015-01       Impact factor: 8.739

5.  Posttraumatic Stress Disorder Is Associated with Increased Risk of Ovarian Cancer: A Prospective and Retrospective Longitudinal Cohort Study.

Authors:  Laura D Kubzansky; Shelley S Tworoger; Andrea L Roberts; Tianyi Huang; Karestan C Koenen; Yongjoo Kim
Journal:  Cancer Res       Date:  2019-09-05       Impact factor: 12.701

6.  Changes in urinary metabolic profiles of colorectal cancer patients enrolled in a prospective cohort study (ColoCare).

Authors:  David B Liesenfeld; Nina Habermann; Reka Toth; Robert W Owen; Eva Frei; Jürgen Staffa; Petra Schrotz-King; Karel D Klika; Cornelia M Ulrich
Journal:  Metabolomics       Date:  2014-12-20       Impact factor: 4.290

Review 7.  Role of the Nervous System in Tumor Angiogenesis.

Authors:  Nyanbol Kuol; Lily Stojanovska; Vasso Apostolopoulos; Kulmira Nurgali
Journal:  Cancer Microenviron       Date:  2018-03-04

8.  Social Integration, Marital Status, and Ovarian Cancer Risk: A 20-Year Prospective Cohort Study.

Authors:  Claudia Trudel-Fitzgerald; Elizabeth M Poole; Anil K Sood; Olivia I Okereke; Ichiro Kawachi; Laura D Kubzansky; Shelley S Tworoger
Journal:  Psychosom Med       Date:  2019 Nov/Dec       Impact factor: 4.312

9.  Eudaimonic well-being and tumor norepinephrine in patients with epithelial ovarian cancer.

Authors:  Lauren Z Davis; George M Slavich; Premal H Thaker; Michael J Goodheart; David P Bender; Laila Dahmoush; Donna M Farley; Kristian E Markon; Frank J Penedo; David M Lubaroff; Steve W Cole; Anil K Sood; Susan K Lutgendorf
Journal:  Cancer       Date:  2015-06-10       Impact factor: 6.860

Review 10.  Lymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches.

Authors:  Caroline P Le; Tara Karnezis; Marc G Achen; Steven A Stacker; Erica K Sloan
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2013-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.